Skip to main content
Erschienen in: Supportive Care in Cancer 5/2004

01.05.2004 | Original Article

Assessment of peri-operative quality of life in patients undergoing surgery for gastrointestinal cancer

verfasst von: Toshiko Matsushita, Eisuke Matsushima, Michio Maruyama

Erschienen in: Supportive Care in Cancer | Ausgabe 5/2004

Einloggen, um Zugang zu erhalten

Abstract

The purpose of this study was to assess the pre- and postoperative quality of life (QOL) of patients with gastrointestinal cancer and to investigate the relationship between QOL and various psychological and clinical factors. Eighty-five patients who underwent surgery for gastrointestinal cancer and 26 control patients undergoing surgery for digestive diseases other than cancer were interviewed. Two tests were administered to assess QOL and psychological status respectively: the Japanese-language version of the European Organization for Research and Treatment of Cancer (EORTC) QLQ-C30 and the Japanese-language version of the Hospital Anxiety and Depression Scale (HADS). Each test was administered before surgery, before discharge, and 6 months after discharge. Gastrointestinal tumors were localized to the stomach, colon, or rectum in 88% of cases and classified as advanced stage or early stage according to staging protocols. Changes in EORTC QLQ-C30 subscale scores over time were compared among advanced stage, early stage, and control patients. All groups showed significant changes in subscale scores of QOL; the scores of the advanced-stage group indicated worse QOL than the early-stage and control groups in a lot of areas. The physical function (PF2) QOL subscore was influenced by diagnosis, postoperative complications, medical equipment at discharge, and the length of admission and negatively correlated with depression and anxiety. These results suggest that QOL in gastrointestinal cancer patients is variable over time and is influenced by various clinical factors. Therefore, consideration of these clinical factors is paramount to the optimal care of gastrointestinal cancer patients.
Literatur
1.
Zurück zum Zitat Aaronson NK, Ahmedzai S, Bergman B, et al (1993)The European Organization for Research and Treatment of Cancer QLQ-30; A quality-of-life instrument of use in international clinical trials in oncology. Journal of the National Cancer Institute 85:365–376CrossRefPubMed Aaronson NK, Ahmedzai S, Bergman B, et al (1993)The European Organization for Research and Treatment of Cancer QLQ-30; A quality-of-life instrument of use in international clinical trials in oncology. Journal of the National Cancer Institute 85:365–376CrossRefPubMed
2.
Zurück zum Zitat Andrew Bottomley (2001) Developing clinical trial protocols for quality of life assessment. Applied Clinical Trials January: 1–5 Andrew Bottomley (2001) Developing clinical trial protocols for quality of life assessment. Applied Clinical Trials January: 1–5
3.
Zurück zum Zitat Brunelli C, Mosconi P, Boeri P, et al (2000) Evaluation of quality of life in patients with malignant dysphagia. Tumori 86:134–138PubMed Brunelli C, Mosconi P, Boeri P, et al (2000) Evaluation of quality of life in patients with malignant dysphagia. Tumori 86:134–138PubMed
4.
5.
Zurück zum Zitat Coates A, Porzsolt F, Osoba D (1997) Quality of life in oncology practice: prognostic value of EORTC QOL-30 scores in patients with advanced malignancy. Euro J Cancer 33:1025–1030CrossRef Coates A, Porzsolt F, Osoba D (1997) Quality of life in oncology practice: prognostic value of EORTC QOL-30 scores in patients with advanced malignancy. Euro J Cancer 33:1025–1030CrossRef
6.
Zurück zum Zitat Doyle C,Crump M,Pintilie M,Oza AM (2001) Does palliative chemotherapy palliate? Evaluation of expectations, outcomes, and costs in women receiving chemotherapy for advanced ovarian cancer. J Clin Oncol 19:1266–1274PubMed Doyle C,Crump M,Pintilie M,Oza AM (2001) Does palliative chemotherapy palliate? Evaluation of expectations, outcomes, and costs in women receiving chemotherapy for advanced ovarian cancer. J Clin Oncol 19:1266–1274PubMed
7.
Zurück zum Zitat Earlam S, Glover C, Fordy C, Burke D, Allen-Mersh TG (1996) Relation between tumor size, quality of life, and survival in patients with colorectal liver metastases. J Clin Oncol 14:171–175PubMed Earlam S, Glover C, Fordy C, Burke D, Allen-Mersh TG (1996) Relation between tumor size, quality of life, and survival in patients with colorectal liver metastases. J Clin Oncol 14:171–175PubMed
8.
Zurück zum Zitat Folstein M, Folstein S, McHugh P (1975) “MINI-MENTAL STATE” A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198PubMed Folstein M, Folstein S, McHugh P (1975) “MINI-MENTAL STATE” A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198PubMed
9.
Zurück zum Zitat Forsberg C, Cedermark B (1996) Well-being, general health and coping ability: 1-year follow-up of patients treated for colorectal and gastric cancer. Eur J Cancer Care 5:209–216 Forsberg C, Cedermark B (1996) Well-being, general health and coping ability: 1-year follow-up of patients treated for colorectal and gastric cancer. Eur J Cancer Care 5:209–216
10.
Zurück zum Zitat Forsberg C, Bjorvell H, Cedermark B (1996) Well-being and its relation to coping ability in patients with colo-rectal and gastric cancer before and after surgery. Scand J caring Sci 10:35–44 Forsberg C, Bjorvell H, Cedermark B (1996) Well-being and its relation to coping ability in patients with colo-rectal and gastric cancer before and after surgery. Scand J caring Sci 10:35–44
11.
Zurück zum Zitat Ganz PA, Lee JJ, Siau J (1991) Quality of life assessment: an independent prognostic variable for survival in lung cancer. Cancer 67:3131–3135PubMed Ganz PA, Lee JJ, Siau J (1991) Quality of life assessment: an independent prognostic variable for survival in lung cancer. Cancer 67:3131–3135PubMed
12.
Zurück zum Zitat Greimel E, Thiel I, Peintinger F, Cegnar I, Pongratz E (2002) Prospective assessment of quality of life of female cancer patients. Gynecol Oncol 85:140–147CrossRefPubMed Greimel E, Thiel I, Peintinger F, Cegnar I, Pongratz E (2002) Prospective assessment of quality of life of female cancer patients. Gynecol Oncol 85:140–147CrossRefPubMed
13.
Zurück zum Zitat Halford S, Yip D, Karapetis CS, et al (2001) A phase II study evaluating the tolerability and efficacy of CAELYX (liposomal doxorubicin, Doxil) in the treatment of unresectable pancreatic carcinoma. Ann Oncol 12:1399–1402CrossRefPubMed Halford S, Yip D, Karapetis CS, et al (2001) A phase II study evaluating the tolerability and efficacy of CAELYX (liposomal doxorubicin, Doxil) in the treatment of unresectable pancreatic carcinoma. Ann Oncol 12:1399–1402CrossRefPubMed
14.
Zurück zum Zitat Hasegawa S, Nakayama K, Utsunomiya K (2001) Journal of Health and Welfare Statistics. Health and Welfare Statistics Association, Tokyo, pp 48–54 Hasegawa S, Nakayama K, Utsunomiya K (2001) Journal of Health and Welfare Statistics. Health and Welfare Statistics Association, Tokyo, pp 48–54
15.
Zurück zum Zitat Hasegawa S, Nakayama K, Utsunomiya K (2001) Journal of Health and Welfare Statistics. Health and Welfare Statistics Association, Tokyo, pp 451–455 Hasegawa S, Nakayama K, Utsunomiya K (2001) Journal of Health and Welfare Statistics. Health and Welfare Statistics Association, Tokyo, pp 451–455
16.
Zurück zum Zitat Herrmann C (1997) International experiences with the hospital anxiety and depression scale a review of validation data and clinical results. J Psycho Res 42:17–41CrossRef Herrmann C (1997) International experiences with the hospital anxiety and depression scale a review of validation data and clinical results. J Psycho Res 42:17–41CrossRef
17.
Zurück zum Zitat Hosaka T, Aoki T.(1996) Depression among cancer patients. Psychiatry Clin Neurosci 50:309–312PubMed Hosaka T, Aoki T.(1996) Depression among cancer patients. Psychiatry Clin Neurosci 50:309–312PubMed
18.
Zurück zum Zitat Japanese Colon Cancer Association (2001) Colon cancer treatment guidelines, Tokyo Japanese Colon Cancer Association (2001) Colon cancer treatment guidelines, Tokyo
19.
Zurück zum Zitat Japanese Esophageal Cancer Association (2001) Esophageal cancer treatment guidelines, Tokyo Japanese Esophageal Cancer Association (2001) Esophageal cancer treatment guidelines, Tokyo
20.
Zurück zum Zitat Japanese Gastric Cancer Association (2001) The first version of gastric cancer treatment guidelines, Tokyo Japanese Gastric Cancer Association (2001) The first version of gastric cancer treatment guidelines, Tokyo
21.
Zurück zum Zitat Japanese Pancreas Cancer Association (2001) Pancreas cancer treatment guidelines, Tokyo Japanese Pancreas Cancer Association (2001) Pancreas cancer treatment guidelines, Tokyo
22.
Zurück zum Zitat Johnston M, Pollard B, Hennessey P (2000) Construct validation of the hospital anxiety and depression scale with clinical populations. J Psychosom Res 48:579–584CrossRefPubMed Johnston M, Pollard B, Hennessey P (2000) Construct validation of the hospital anxiety and depression scale with clinical populations. J Psychosom Res 48:579–584CrossRefPubMed
23.
Zurück zum Zitat Kelsen DP, Portenoy RK, Thaler HT, et al (1995) Pain and depression in patients with newly diagnosed pancreas cancer. J Clin Oncol 13:748–755PubMed Kelsen DP, Portenoy RK, Thaler HT, et al (1995) Pain and depression in patients with newly diagnosed pancreas cancer. J Clin Oncol 13:748–755PubMed
24.
Zurück zum Zitat Kenn C, Wood H, Kucyj M (1987) Validation of the Hospital Anxiety and Depression Rating Scale (HADS) in a elderly psychiatric population. Int J Ger Psychiatry 2:189–193 Kenn C, Wood H, Kucyj M (1987) Validation of the Hospital Anxiety and Depression Rating Scale (HADS) in a elderly psychiatric population. Int J Ger Psychiatry 2:189–193
25.
Zurück zum Zitat Kobayashi K, Takeda F, Teramukai S, et al (1998) A cross-validation of the European Organization for Research and Treatment of cancer QLQ-C30 (EORTC QLQ-C30) for Japanese with lung cancer. Eur J Cancer 34:810–815CrossRefPubMed Kobayashi K, Takeda F, Teramukai S, et al (1998) A cross-validation of the European Organization for Research and Treatment of cancer QLQ-C30 (EORTC QLQ-C30) for Japanese with lung cancer. Eur J Cancer 34:810–815CrossRefPubMed
26.
Zurück zum Zitat Kono K, Iizuka H, Sekikawa T, et al (2003) Improved quality of life with jejunal pouch reconstruction after total gastrectomy. Am J Surg 185:150-154CrossRefPubMed Kono K, Iizuka H, Sekikawa T, et al (2003) Improved quality of life with jejunal pouch reconstruction after total gastrectomy. Am J Surg 185:150-154CrossRefPubMed
27.
Zurück zum Zitat Matsushima E (2002) The study of psycho-oncology in a general surgical ward. Health welfare scientific research “The study of palliative care & psycho-oncology in cancer treatment” 39–40 (in Japanese) Matsushima E (2002) The study of psycho-oncology in a general surgical ward. Health welfare scientific research “The study of palliative care & psycho-oncology in cancer treatment” 39–40 (in Japanese)
28.
Zurück zum Zitat Norum J, Balteskard L, Edna TH, Laino R, Wahlby L, Ronning G (2002) Ralitrexed (Tomudex) or Nordic-FLv regimen in metastatic colorectal cancer: a randomized phase II study focusing on quality of life, patients’ preferences and health economics. J Chemother 14:301–308PubMed Norum J, Balteskard L, Edna TH, Laino R, Wahlby L, Ronning G (2002) Ralitrexed (Tomudex) or Nordic-FLv regimen in metastatic colorectal cancer: a randomized phase II study focusing on quality of life, patients’ preferences and health economics. J Chemother 14:301–308PubMed
29.
Zurück zum Zitat Ouchi K, Sugawara T, Ono H, et al (1998) Therapeutic significance of palliative operations for gastric cancer for survival and quality of life. J Surg Oncol 69:41–44CrossRefPubMed Ouchi K, Sugawara T, Ono H, et al (1998) Therapeutic significance of palliative operations for gastric cancer for survival and quality of life. J Surg Oncol 69:41–44CrossRefPubMed
30.
Zurück zum Zitat Ouchi K, Sugawara T, Ono H, et al (1998) Palliative operation for cancer of the head of the pancreas: significance of pancreaticoduodenectomy and intraoperative radiation therapy for survival and quality of life. World J Surg 22:413–416CrossRefPubMed Ouchi K, Sugawara T, Ono H, et al (1998) Palliative operation for cancer of the head of the pancreas: significance of pancreaticoduodenectomy and intraoperative radiation therapy for survival and quality of life. World J Surg 22:413–416CrossRefPubMed
31.
Zurück zum Zitat Padilla GV, Grant MM, Lipsett J, Anderson PR, Rhiner M, Bogen C (1992) Health quality of life and colo-rectal cancer. Cancer Suppl 70:1450–1456 Padilla GV, Grant MM, Lipsett J, Anderson PR, Rhiner M, Bogen C (1992) Health quality of life and colo-rectal cancer. Cancer Suppl 70:1450–1456
32.
Zurück zum Zitat Portenoy RK, Thaler HT, Kornblith AB, et al (1994) Symptom prevalence, characteristics and distress in a cancer population. Qual Life Res 3:183–189PubMed Portenoy RK, Thaler HT, Kornblith AB, et al (1994) Symptom prevalence, characteristics and distress in a cancer population. Qual Life Res 3:183–189PubMed
33.
Zurück zum Zitat Ringdal GI, Ringdal K, Kvinnsland S, Gotestam KG (1994) Quality of life of cancer patients with different prognoses. Qual Life Res 3:143–154PubMed Ringdal GI, Ringdal K, Kvinnsland S, Gotestam KG (1994) Quality of life of cancer patients with different prognoses. Qual Life Res 3:143–154PubMed
34.
Zurück zum Zitat Shimozuma K, Katsumata N, Ohashi Y, Makino H, Takashima S, Sonoo H (1999) Impact of surgical adjuvant chemotherapy on quality of life (QOL) of patients with breast cancer (BC)-A phase randomized trial comparing UFT(Uracil/Tegafur)with CMF in high-risk node negative patients. Proceeding of 35th Annual Meeting of ASCO, pp 579a Shimozuma K, Katsumata N, Ohashi Y, Makino H, Takashima S, Sonoo H (1999) Impact of surgical adjuvant chemotherapy on quality of life (QOL) of patients with breast cancer (BC)-A phase randomized trial comparing UFT(Uracil/Tegafur)with CMF in high-risk node negative patients. Proceeding of 35th Annual Meeting of ASCO, pp 579a
35.
Zurück zum Zitat Spector NM, Hicks FD, Pickleman J (2002) Quality of life and symptoms after surgery for gastroesophageal cancer: a pilot study. Gastroenterol Nurs 25:120–125CrossRefPubMed Spector NM, Hicks FD, Pickleman J (2002) Quality of life and symptoms after surgery for gastroesophageal cancer: a pilot study. Gastroenterol Nurs 25:120–125CrossRefPubMed
36.
Zurück zum Zitat Sprangers MA, Cull A, Bjordal K, Groenvold M, Aaronson NK (1993) The European Organization for Research and Treatment of Cancer approach to quality of life assessment: guideline for developing questionnaire modules. Qual Life Res 2:287–295PubMed Sprangers MA, Cull A, Bjordal K, Groenvold M, Aaronson NK (1993) The European Organization for Research and Treatment of Cancer approach to quality of life assessment: guideline for developing questionnaire modules. Qual Life Res 2:287–295PubMed
37.
Zurück zum Zitat Von Essen L, Larsson G, Oberg K, Sjoden PO (2002) “Satisfaction with care”: associations with health-related quality of life and psychosocial function among Swedish patients with endocrine gastrointestinal tumors. Eur J Cancer Care 11:91–99CrossRef Von Essen L, Larsson G, Oberg K, Sjoden PO (2002) “Satisfaction with care”: associations with health-related quality of life and psychosocial function among Swedish patients with endocrine gastrointestinal tumors. Eur J Cancer Care 11:91–99CrossRef
38.
Zurück zum Zitat Williams NS, Johnston D (1983) The quality of life after rectal excision for low rectal cancer. Br J Surg 70:460–462PubMed Williams NS, Johnston D (1983) The quality of life after rectal excision for low rectal cancer. Br J Surg 70:460–462PubMed
39.
Zurück zum Zitat Wu CW, Lo SS, Shen KH, Hsieh MC, Lui WY, P’eng FK (2000) Surgical mortality, survival, and quality of life after resection for gastric cancer in the elderly. World J Surg 24:465–472CrossRefPubMed Wu CW, Lo SS, Shen KH, Hsieh MC, Lui WY, P’eng FK (2000) Surgical mortality, survival, and quality of life after resection for gastric cancer in the elderly. World J Surg 24:465–472CrossRefPubMed
40.
Zurück zum Zitat Yasue M, Sakamoto J, Morimoto T, et al (1995) Evaluation of the effect of pancreatic resection in advanced pancreatic cancer with special reference using hospital-free survival as a measure of quality of life. Jpn J Clin Oncol 25:37–45PubMed Yasue M, Sakamoto J, Morimoto T, et al (1995) Evaluation of the effect of pancreatic resection in advanced pancreatic cancer with special reference using hospital-free survival as a measure of quality of life. Jpn J Clin Oncol 25:37–45PubMed
41.
Zurück zum Zitat Zigmond AS, Snaith RP (1983) The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 67:361–370PubMed Zigmond AS, Snaith RP (1983) The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 67:361–370PubMed
42.
Zurück zum Zitat Zigmond AS, Snaith RP, Kitamura translation (1993) Hospital Anxiety and Depression Scale (HAD Scale) (in Japanese). Archives of Psychiatric Diagnostics and Clinical Evaluation 4:371–372 Zigmond AS, Snaith RP, Kitamura translation (1993) Hospital Anxiety and Depression Scale (HAD Scale) (in Japanese). Archives of Psychiatric Diagnostics and Clinical Evaluation 4:371–372
Metadaten
Titel
Assessment of peri-operative quality of life in patients undergoing surgery for gastrointestinal cancer
verfasst von
Toshiko Matsushita
Eisuke Matsushima
Michio Maruyama
Publikationsdatum
01.05.2004
Verlag
Springer-Verlag
Erschienen in
Supportive Care in Cancer / Ausgabe 5/2004
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-004-0618-1

Weitere Artikel der Ausgabe 5/2004

Supportive Care in Cancer 5/2004 Zur Ausgabe

Forthcoming Meetings

May 2004

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

CUP-Syndrom: Künstliche Intelligenz kann Primärtumor finden

30.04.2024 Künstliche Intelligenz Nachrichten

Krebserkrankungen unbekannten Ursprungs (CUP) sind eine diagnostische Herausforderung. KI-Systeme können Pathologen dabei unterstützen, zytologische Bilder zu interpretieren, um den Primärtumor zu lokalisieren.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.